Diagnosis and treatment of premature ejaculation: The physician's perspective

Journal of Sexual Medicine

Volumn 2, Issue SUPPL. 2, 2005, Pages 103-109

  Sharlip, Ira ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

Intravaginal ejaculatory latency time; Phosphodiesterase 5 (PDE 5) inhibitors; Premature ejaculation; Seretonin

Indexed keywords

(2,5 DIMETHOXY 4 IODOPHENYL) 2 AMINOPROPANE; ANESTHETIC AGENT; CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; HERBACEOUS AGENT; LIDOCAINE; PAROXETINE; PHOSPHODIESTERASE V INHIBITOR; PRILOCAINE; SEROTONIN 2A AGONIST; SEROTONIN 2C AGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; UNCLASSIFIED DRUG;

ANORGASMIA; ANTICHOLINERGIC EFFECT; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE DEFECT; DROWSINESS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; EJACULATION DISORDER; ERECTILE DYSFUNCTION; EVIDENCE BASED MEDICINE; FEMALE SEXUAL DYSFUNCTION; HUMAN; LIBIDO DISORDER; LICENCE; MALE; MALE SEXUAL DYSFUNCTION; MENSTRUATION DISORDER; NAUSEA; PHYSICIAN ATTITUDE; PREMATURE EJACULATION; PRIORITY JOURNAL; PSYCHOTHERAPY; QUALITY OF LIFE; SENSORY DYSFUNCTION; SEXUAL FUNCTION; SIDE EFFECT; TOPICAL ANESTHESIA; VAGINA DISEASE;

EID: 19644394548     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2005.20370.x     Document Type: Article

References (41)

1. Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, Nehra A, Sharlip ID, AUA Erectile Dysfunction Guideline Update Panel. AUA guideline on the pharmacologic management of premature ejaculation. J Urol 2004;172:290-4.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Text revision. Washington, DC: American Psychiatric Association; 2000.
3. McCabe MP. Intimacy and quality of life among sexually dysfunctional men and women. J Sex Marital Ther 1997;23:276-90.
4. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999;281:537-44.
5. Symonds T, Roblin D, Hart K, Althof S. How does premature ejaculation impact a mans life? J Sex Marital Ther 2003;29:361-70.
6. World Health Organization. International classification of diseases and related health problems. Geneva: World Health Organization; 1994.
7. Screponi E, Carosa E, Di Stasi SM, Pepe M, Carruba G, Jannini EA. Prevalence of chronic prostatitis in men with premature ejaculation. Urology 2001;58:198-202.
8. El-Sakka AI. Premature ejaculation in non-insulin-dependent diabetic patients. Int J Androl 2 003;26: 329-34.
9. Metz ME, Pryor JL. Premature ejaculation: A psychophysiological approach for assessment and management. J Sex Marital Ther 2000;26:293-320.
10. Clayton DO, Shen WW. Psychotropic drug-induced sexual function disorders: Diagnosis, incidence and management. Drug Saf 1998;19:299-312.
11. Semans JH. Premature ejaculation: A new approach. South Med J 1956;49:353-8.
12. Masters W, Johnson V. Premature ejaculation. In: Masters W, Johnson V, eds. Human sexual inadequacy. Boston, MA: Little Brown & Co; 1970.
13. Kaplan H. The evaluation of sexual disorders: Psychological and medical aspects. New York, NY: Taylor Francis; 1983.
14. Clarke M, Parry L. Premature ejaculation treated by the dual sex team method of Masters and Johnson. Aust N Z J Psychiatry 1973;7:200-5.
15. De Amicis LA, Goldberg DC, LoPiccolo J, Friedman J, Davies L. Clinical follow-up of couples treated for sexual dysfunction. Arch Sex Behav 1985;14:467-89.
16. Xin Z, Choi Y, Lee S, Choi H. Efficacy of a topical agent SS-cream in the treatment of premature ejaculation: Preliminary clinical studies. Yonsei Med J 1997;38:91-5.
17. Choi HK, Jung GW, Moon KH, Xin ZC, Choi YD, Lee WH, Rha KH, Choi YJ, Kim DK. Clinical study of SS-cream in patients with lifelong premature ejaculation. Urology 2000;55:257-61.
18. McMahon CG, Samali R. Pharmacological treatment of premature ejaculation. Curr Opin Urol 1999;9:553-61.
19. Slob A, van Berke A, van der Werff ten Bosch J. Premature ejaculation treated by local penile anaesthesia in an uncontrolled clinical replication study. J Sex Res 2000;37:244-7.
20. Stief CG. Phosphodiesterase inhibitors in the treatment of erectile dysfunction. Drugs Today (Barc) 2000;36:93-9.
21. Aversa A, Mazzilli F, Rossi T, Delfino M, Isidori AM, Fabbri A. Effects of sildenafil (Viagra) administration on seminal parameters and postejaculatory refractory time in normal males. Hum Reprod 2000;15:131-4.
22. Mondaini N, Ponchietti R, Muir GH, Montorsi F, Di Loro F, Lombardi G, Rizzo M. Sildenafil does not improve sexual function in men without erectile dysfunction but does reduce the postorgasmic refractory time. Int J Impot Res 2003;15:225-8.
23. Abdel-Hamid IA. Phosphodiesterase 5 inhibitors in rapid ejaculation: Potential use and possible mechanisms of action. Drugs 2004;64:13-26.
24. Ahlenius S, Heimann M, Larsson K. Prolongation of the ejaculation latency in the male rat by thioridazine and chlorimipramine. Psychopharmacology (Berl) 1979;65:137-40.
25. Goodman RE. An assessment of clomipramine (Anafranil) in the treatment of premature ejaculation. J Int Med Res 1980;8(3 suppl):53-9.
26. Girgis SM, El-Haggar S, El-Hermouzy S. A double-blind trial of clomipramine in premature ejaculation. Andrologia 1982;14:364-8.
27. Kim SC, Seo KK. Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: A double-blind, placebo controlled study. J Urol 1998;159:425-7.
28. Meisel R, Sachs B. The physiology of male sexual behavior. In: Knobil E, Neill J, Greenwald G, Markert C, Pfaff D, eds. The physiology of reproduction. Vol. 3-107. New York: Raven; 1997.
29. Bancila M, Giuliano F, Rampin O, Mailiy P, Brisorgueil MJ, Calas A, Verge D. Evidence for a direct projection from the paraventricular nucleus of the hypothalamus to putative serotoninergic neurons of the nucleus paragigantocellularis involved in the control of erection in rats. Eur J Neurosci 2002;16:1240-8.
30. Waldinger MD. The neurobiological approach to premature ejaculation. J Urol 2002;168:2359-67.
31. Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999;38:1083-152.
32. Stamford JA, Davidson C, McLaughlin DP, Hopwood SE. Control of dorsal raphe 5-HT function by multiple 5-HT(1) autoreceptors: Parallel purposes or pointless plurality? Trends Neurosci 2000;23:459-65.
33. Waldinger MD, Berendsen HH, Blok BF, Olivier B, Holstege G. Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: The involvement of the serotonergic system. Behav Brain Res 1998;92:111-8.
34. Ahlenius S, Larsson K, Svensson L, Hjorth S, Carlsson A, Lindberg P, Wilkstrom H, Sanchez D, Arvidsson LE, Hacksell U, Nilsson JL. Effects of a new type of 5-HT receptor agonist on male rat sexual behavior. Pharmacol Biochem Behav 1981;15:785-92.
35. Foreman MM, Hall JL, Love RL. The role of the 5-HT2 receptor in the regulation of sexual performance of male rats. Life Sci 1989;45:1263-70.
36. Berendsen HH, Broekkamp CL. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice. Br J Pharmacol 1990;101:667-73.
37. Waldinger MD, Hengeveld MW, Zwinderman AH. Paroxetine treatment of premature ejaculation: A double-blind, randomized, placebo-controlled study. Am J Psychiatry 1994;151:1377-9.
38. Mendels J, Camera A, Sikes C. Sertraline treatment for premature ejaculation. J Clin Psychopharmacol 1995;15:341-6.
39. McMahon CG. Treatment of premature ejaculation with sertraline hydrochloride: A single-blind placebo controlled crossover study. J Urol 1998; 159:1935-8.
40. Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B. Effect of SSRI antidepressants on ejaculation: A double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol 1998b;18:274-81.
41. Waldinger MD, Zwinderman AH, Olivier B. On-demand treatment of premature ejaculation with clomiprantine and paroxetine: A randomized, double-blind fixed-dose study with stopwatch assessment. Eur Urol 2004;46:510-15; discussion 516.